Northern Trust’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.9M | Sell |
602,898
-3,794
| -0.6% | -$49.7K | ﹤0.01% | 2204 |
|
|
2025
Q1 | $13.3M | Sell |
606,692
-4,614
| -0.8% | -$102K | ﹤0.01% | 1874 |
|
|
2024
Q4 | $16.3M | Buy |
611,306
+35,426
| +6% | +$946K | ﹤0.01% | 1827 |
|
|
2024
Q3 | $15.4M | Buy |
575,880
+67,189
| +13% | +$1.79M | ﹤0.01% | 1798 |
|
|
2024
Q2 | $9.16M | Buy |
508,691
+9,171
| +2% | +$165K | ﹤0.01% | 2045 |
|
|
2024
Q1 | $9.11M | Buy |
499,520
+136,277
| +38% | +$2.49M | ﹤0.01% | 2092 |
|
|
2023
Q4 | $3.97M | Buy |
363,243
+18,327
| +5% | +$200K | ﹤0.01% | 2637 |
|
|
2023
Q3 | $1.98M | Buy |
344,916
+5,459
| +2% | +$31.3K | ﹤0.01% | 2948 |
|
|
2023
Q2 | $2.63M | Buy |
339,457
+33,373
| +11% | +$259K | ﹤0.01% | 2851 |
|
|
2023
Q1 | $2.04M | Sell |
306,084
-10,748
| -3% | -$71.7K | ﹤0.01% | 2930 |
|
|
2022
Q4 | $2.83M | Buy |
316,832
+77,932
| +33% | +$697K | ﹤0.01% | 2810 |
|
|
2022
Q3 | $2.35M | Buy |
238,900
+21,633
| +10% | +$213K | ﹤0.01% | 2929 |
|
|
2022
Q2 | $1.73M | Sell |
217,267
-76,685
| -26% | -$611K | ﹤0.01% | 3132 |
|
|
2022
Q1 | $2.85M | Sell |
293,952
-8,238
| -3% | -$79.9K | ﹤0.01% | 2913 |
|
|
2021
Q4 | $4.62M | Buy |
302,190
+186,617
| +161% | +$2.85M | ﹤0.01% | 2730 |
|
|
2021
Q3 | $1.92M | Sell |
115,573
-11,156
| -9% | -$185K | ﹤0.01% | 3314 |
|
|
2021
Q2 | $2.7M | Buy |
+126,729
| New | +$2.7M | ﹤0.01% | 3212 |
|